Literature DB >> 2369747

Gastric precancerous process in a high risk population: cross-sectional studies.

P Correa1, W Haenszel, C Cuello, D Zavala, E Fontham, G Zarama, S Tannenbaum, T Collazos, B Ruiz.   

Abstract

The gastric precancerous process is evaluated in 1788 participants in a gastroscopy survey in the population of Nariño, Colombia, which has one of the highest gastric cancer incidence rates on record. A detailed histological classification is used, and a hierarchical distribution of lesions is described with the main stages being gland neck hyperplasia, atrophy (gland loss), intestinal metaplasia and dysplasia. Acute inflammation was not found to be a specific stage in the sequence but rather a common finding in all stages of the precancerous spectrum. Indices of disease progression for the different steps are calculated and found to increase with gastric pH and nitrate and nitrite content of the gastric juice. The effects of high pH and nitrite content are intimately correlated. Relative risks of specific lesions, namely, hyperplasia, atrophy, metaplasia, and dysplasia, increase linearly with higher pH, nitrate, and nitrite values in the gastric juice. The severity of atrophy correlates with the prevalence of metaplasia, suggesting a sequential relationship between the described stages, a finding supported by all parameters examined. The model of progression described may serve as a basis for comparisons with populations at different levels of gastric cancer risk but it fails to provide information concerning the time required for each change, which should be provided by follow-up (cohort) studies.

Entities:  

Mesh:

Year:  1990        PMID: 2369747

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

Review 1.  Gastric epithelial dysplasia.

Authors:  G Y Lauwers; R H Riddell
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

2.  Comparison of precancerous conditions: atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients.

Authors:  X Y Chen; R W van Der Hulst; Y Shi; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  2001-05       Impact factor: 3.411

Review 3.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

Review 4.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

5.  B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis.

Authors:  S Nakamura; K Aoyagi; M Furuse; H Suekane; T Matsumoto; T Yao; Y Sakai; T Fuchigami; I Yamamoto; M Tsuneyoshi; M Fujishima
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

Review 6.  Clinical impact of tumour biology in the management of gastroesophageal cancer.

Authors:  Florian Lordick; Yelena Y Janjigian
Journal:  Nat Rev Clin Oncol       Date:  2016-03-01       Impact factor: 66.675

7.  Epidemiological and viral genome characteristics of the first human H7N9 influenza infection in Guangdong Province, China.

Authors:  Zi-Feng Yang; Jian-Feng He; Xiao-Bo Li; Wen-Da Guan; Chang-Wen Ke; Shi-Guan Wu; Si-Hua Pan; Run-Feng Li; Min Kang; Jie Wu; Jin-Yan Lin; Guo-Yun Ding; Ji-Cheng Huang; Wei-Qi Pan; Rong Zhou; Yong-Ping Lin; Rong-Chang Chen; Yi-Min Li; Ling Chen; Wen-Long Xiao; Yong-Hui Zhang; Nan-Shan Zhong
Journal:  J Thorac Dis       Date:  2014-12       Impact factor: 2.895

Review 8.  Does gastric atrophy exist in children?

Authors:  Georges Dimitrov; Frederic Gottrand
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

9.  Exploring the cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer in China in anticipation of clinical trial results.

Authors:  Jennifer M Yeh; Karen M Kuntz; Majid Ezzati; Sue J Goldie
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

10.  Inactivation of NKX6.3 in the stomach leads to abnormal expression of CDX2 and SOX2 required for gastric-to-intestinal transdifferentiation.

Authors:  Jung H Yoon; Sung S Choi; Olga Kim; Won S Choi; Yong K Park; Suk W Nam; Jung Y Lee; Won S Park
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.